Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Lazertinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,927Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Centocor

    02 6Janssen-Cilag

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Centocor

    U.S.A
    Health 2.0 Conference
    Not Confirmed
    arrow

    Centocor

    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAZERTINIB MESYLATE

    Brand Name : LAZCLUZE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 80MG BASE

    Packaging :

    Approval Date : 2024-08-19

    Application Number : 219008

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Centocor

    U.S.A
    Health 2.0 Conference
    Not Confirmed
    arrow

    Centocor

    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    LAZERTINIB MESYLATE

    Brand Name : LAZCLUZE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 240MG BASE

    Packaging :

    Approval Date : 2024-08-19

    Application Number : 219008

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Centocor

    U.S.A
    Health 2.0 Conference
    Not Confirmed
    arrow

    Centocor

    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : PRESCRIPTION

    Registration Country : Canada

    LAZERTINIB (LAZERTINIB MESYLATE)

    Brand Name : LAZCLUZE

    Dosage Form : TABLET

    Dosage Strength : 80MG

    Packaging :

    Approval Date :

    Application Number : 2555964

    Regulatory Info : PRESCRIPTION

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Centocor

    U.S.A
    Health 2.0 Conference
    Not Confirmed
    arrow

    Centocor

    U.S.A
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : PRESCRIPTION

    Registration Country : Canada

    LAZERTINIB (LAZERTINIB MESYLATE)

    Brand Name : LAZCLUZE

    Dosage Form : TABLET

    Dosage Strength : 240MG

    Packaging :

    Approval Date :

    Application Number : 2555972

    Regulatory Info : PRESCRIPTION

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Janssen-Cilag

    Italy
    Health 2.0 Conference
    Not Confirmed
    arrow

    Janssen-Cilag

    Italy
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Estonia

    Lazertinib

    Brand Name : Lazcluze

    Dosage Form : Film-Coated Tablet

    Dosage Strength : 240mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Prescription

    Registration Country : Estonia

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Janssen-Cilag

    Italy
    Health 2.0 Conference
    Not Confirmed
    arrow

    Janssen-Cilag

    Italy
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Estonia

    Lazertinib

    Brand Name : Lazcluze

    Dosage Form : Film-Coated Tablet

    Dosage Strength : 80mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info : Prescription

    Registration Country : Estonia

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Janssen-Cilag

    Italy
    Health 2.0 Conference
    Not Confirmed
    arrow

    Janssen-Cilag

    Italy
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Authorized

    Registration Country : Spain

    Lazertinib

    Brand Name : Lazcluze

    Dosage Form : Film Coated Tablet

    Dosage Strength : 80MG

    Packaging :

    Approval Date : 29-01-2025

    Application Number : 1241886001

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Janssen-Cilag

    Italy
    Health 2.0 Conference
    Not Confirmed
    arrow

    Janssen-Cilag

    Italy
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Authorized

    Registration Country : Spain

    Lazertinib

    Brand Name : Lazcluze

    Dosage Form : Film Coated Tablet

    Dosage Strength : 240MG

    Packaging :

    Approval Date : 29-01-2025

    Application Number : 1241886005

    Regulatory Info : Authorized

    Registration Country : Spain

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Janssen-Cilag

    Italy
    Health 2.0 Conference
    Not Confirmed
    arrow

    Janssen-Cilag

    Italy
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Denmark

    Lazertinib

    Brand Name : Lazcluze

    Dosage Form : Film Coated Tablet

    Dosage Strength : 240mg

    Packaging :

    Approval Date : 20-01-2025

    Application Number : 28107094023

    Regulatory Info : Prescription

    Registration Country : Denmark

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Janssen-Cilag

    Italy
    Health 2.0 Conference
    Not Confirmed
    arrow

    Janssen-Cilag

    Italy
    arrow
    Health 2.0 Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Denmark

    Lazertinib

    Brand Name : Lazcluze

    Dosage Form : Film Coated Tablet

    Dosage Strength : 80mg

    Packaging :

    Approval Date : 20-01-2025

    Application Number : 28107093923

    Regulatory Info : Prescription

    Registration Country : Denmark

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.